29,156 results match your criteria Anemia Chronic


Predictive factors of anemia during sofosbuvir and ribavirin therapy for genotype 2 chronic hepatitis C patients.

Hepatol Res 2019 Apr 22. Epub 2019 Apr 22.

Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Aim: Sofosbuvir (SOF) and ribavirin (RBV) combination therapy has improved the sustained response rate (SVR) and shortened the treatment duration for patients with chronic HCV genotype 2 infection. RBV-induced hemolytic anemia is one of the most troublesome side effects of SOF/RBV therapy; however, factors associated with this condition have not been fully elucidated. We aimed to identify a safer way to complete treatment with SOF/RBV therapy by examining factors related to RBV-induced hemolytic anemia and identifying patients who did not develop anemia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.13354DOI Listing

Orthopedic and orthodontic management in a patient with DiGeorge Syndrome and Familial Mediterranean Fever: A case report.

Spec Care Dentist 2019 Apr 22. Epub 2019 Apr 22.

Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

Aim: The aim of this study is to report the case of the orthopedic and orthodontic treatment in a young patient affected by DiGeorge Syndrome and Familial Mediterranean Fever.

Case Report: An 8-year-old boy with dysmorphic facial features was brought to our observation. Anamnesis revealed signs of fetal respiratory distress, previous surgically removed subdural hematoma, recurrent episodes of fever, arthralgia, polyserositis, hepatosplenomegaly, chronic interstitial nephritis with hypertension, microprotenuria, normocytic anemia, hyperparathyroidism and secondary amyloidosis. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/scd.12381
Publisher Site
http://dx.doi.org/10.1111/scd.12381DOI Listing
April 2019
1 Read

Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries.

Ann N Y Acad Sci 2019 Apr 22. Epub 2019 Apr 22.

Department of Pediatrics, Emory University, Atlanta, Georgia.

Anemia affects a third of the world's population and contributes to increased morbidity and mortality, decreased work productivity, and impaired neurological development. Understanding anemia's varied and complex etiology is crucial for developing effective interventions that address the context-specific causes of anemia and for monitoring anemia control programs. We outline definitions and classifications of anemia, describe the biological mechanisms through which anemia develops, and review the variety of conditions that contribute to anemia development. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/nyas.14092
Publisher Site
http://dx.doi.org/10.1111/nyas.14092DOI Listing
April 2019
1 Read

Coombs-positive refractory acquired thrombotic thrombocytopenic purpura in a patient with chronic myelomonocytic leukemia successfully treated with rituximab.

Acta Clin Belg 2019 Apr 22:1-5. Epub 2019 Apr 22.

b Intensive Care Unit, Department of Internal Medicine , University Hospital Centre Zagreb , Zagreb , Croatia.

Objectives: Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare autoimmune disorder characterized by auto-antibodies to Willebrand factor (vWF) cleaving enzyme (ADAMTS13), resulting in unusually large vWF multimers that lead to platelet aggregation, microthrombi formation and microangiopathic hemolytic anemia. Hemolysis in aTTP is mechanical; thus, direct antiglobulin test (Coombs test) is usually negative. Multiple autoimmune conditions and various auto-antibodies have been described in the context of chronic myelomonocytic leukemia (CMML). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17843286.2019.1608395DOI Listing

Adverse effects of chronic treatment with the Main subclasses of highly active antiretroviral therapy: a systematic review.

HIV Med 2019 Apr 22. Epub 2019 Apr 22.

Adipose Tissue Research Group, Department of Physiological Sciences, State University of Maringá, Maringá, Brazil.

Objectives: The aim of the review was to elucidate the adverse effects of chronic treatment with the main subclasses of highly active antiretroviral therapy (HAART).

Methods: A systematic review was carried out using the methods recommended in the Preferred Reporting Items for Systematic Review and Meta-analysis Protocols (PRISMA-P). Searches of articles in MEDLINE, SCIELO, Web of Science and LILACS were conducted from January to October 2018 based on the following descriptors and keywords: 'HIV' [AND]; 'AIDS' [OR]; 'HAART' [AND]; 'Highly Active Antiretroviral Therapy' [OR]; 'Adverse Effects' [AND]. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hiv.12733DOI Listing

Cardiovascular manifestations of sickle cell disease.

Eur Heart J 2019 Apr 21. Epub 2019 Apr 21.

Sorbonne Université, Inserm, Institute of Cardiometabolism and Nutrition (ICAN), ACTION Study Group and Department of Cardiology, Institute of Cardiology (AP-HP), Hôpital Pitié- Salpêtrière, Boulevard de l'hôpital, Paris F-75013, France.

Sickle cell disease (SCD) is the most frequent genetic haemoglobinopathy worldwide. Early childhood mortality has dramatically decreased in high-income countries, and most patients now survive beyond the 5th decade. However, in the aging SCD population, the morbidity related to chronic organ damage, especially kidney and heart, has become a major concern. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz217DOI Listing

Hunter syndrome with persistent thrombocytopenia.

BMJ Case Rep 2019 Apr 20;12(4). Epub 2019 Apr 20.

Department of Pediatrics, APC, PGIMER, Chandigarh, India.

A case of Hunter syndrome, 6½-year-old boy presented with persistent thrombocytopenia and bleeding diathesis. However, cytopenia is not a usual presentation in patients with mucopolysaccharidosis II. After ruling out other causes of severe thrombocytopenia, a clinical possibility of chronic Epstein-Barr virus (EBV) infection was considered. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2018-226518DOI Listing

The Effect of Recombinant Human Erythropoietin on Bacterial Growth: A Dual-Edged Sword.

Kidney Dis (Basel) 2019 Mar 13;5(2):81-90. Epub 2018 Nov 13.

Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Background: Hypererythropoietinemia is associated with common diseases like non-uremic anaemia where infection burden is high. Erythropoietin (EPO) is also given as therapy for anaemia associated with chronic kidney disease and cancer and in those who are at a higher risk of infections. EPO is known to have an effect on macrophages by which it helps in the growth of some intracellular pathogens. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/493684
Publisher Site
http://dx.doi.org/10.1159/000493684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468308PMC
March 2019
3 Reads

Studying anemia of chronic disease and iron deficiency in patients with rheumatoid arthritis by iron status and circulating hepcidin.

Hematol Rep 2019 Feb 12;11(1):7708. Epub 2019 Mar 12.

Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq.

Anemia of chronic disease (ACD) and iron deficiency anemia (IDA) are the two most important types of anemia in rheumatoid arthritis (RA). Functional iron deficiency in ACD can be attributed to overexpression of the main iron regulatory hormone hepcidin leading to diversion of iron from the circulation into storage sites resulting in iron-restricted erythropoiesis. The aim is to investigate the role of circulating hepcidin and to uncover the frequency of IDA in RA. Read More

View Article

Download full-text PDF

Source
https://www.pagepress.org/journals/index.php/hr/article/view
Publisher Site
http://dx.doi.org/10.4081/hr.2019.7708DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434328PMC
February 2019
1 Read

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Lancet 2019 Apr 12. Epub 2019 Apr 12.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Background: Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without causing significant sodium retention. We report the long-term effects of treatment with atrasentan on major renal outcomes.

Methods: We did this double-blind, randomised, placebo-controlled trial at 689 sites in 41 countries. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)30772-XDOI Listing
April 2019
2 Reads

Acute adrenal haemorrhage in two cats with aldosterone-secreting adenocarcinomas.

JFMS Open Rep 2019 Jan-Jun;5(1):2055116919840828. Epub 2019 Apr 3.

Valentine Charlton Cat Centre, University Veterinary Teaching Hospital, Sydney School of Veterinary Science, Faculty of Science, University of Sydney, NSW, Australia.

Case Summary: Two 13-year-old domestic shorthair cats were diagnosed with unilateral right adrenocortical carcinomas (ACCs) and primary hyperaldosteronism (PHA). Both had polyuria, polydipsia and weight loss, and developed severe anaemia from an episode of acute adrenal haemorrhage. In one case, this occurred during hospitalisation and treatment of severe muscle weakness with cervical ventroflexion, while the other cat had acute collapse at home. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/2055116919840828
Publisher Site
http://dx.doi.org/10.1177/2055116919840828DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449812PMC
April 2019
3 Reads

Rising Serum Uric Acid Level Is Negatively Associated with Survival in Renal Cell Carcinoma.

Cancers (Basel) 2019 Apr 15;11(4). Epub 2019 Apr 15.

Department of Urology, University of California at San Diego, La Jolla, CA, 92093, USA.

To investigate the association of serum uric acid (SUA) levels along with statin use in Renal Cell Carcinoma (RCC), as statins may be associated with improved outcomes in RCC and SUA elevation is associated with increased risk of chronic kidney disease (CKD). Retrospective study of patients undergoing surgery for RCC with preoperative/postoperative SUA levels between 8/2005-8/2018. Analysis was carried out between patients with increased postoperative SUA vs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11040536DOI Listing
April 2019
1 Read

The Hepcidin-Anemia Axis: Pathogenesis of Anemia in Chronic Kidney Disease.

Contrib Nephrol 2019 16;198:124-134. Epub 2019 Apr 16.

Department of Internal Medicine, Division of Kidney and Dialysis, Hyogo College of Medicine, Nishinomiya, Japan.

Background: The pathogenesis of anemia in chronic kidney disease (CKD) could be multifactorial. In recent animal studies, hepcidin knockout (KO) mice with adenine-induced CKD did not exhibit anemia and iron deficiency. Hepcidin has emerged as a major player in the development of anemia in CKD. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/496636
Publisher Site
http://dx.doi.org/10.1159/000496636DOI Listing
April 2019
3 Reads

Hypoxia-Inducible Factor-Prolyl Hydroxylase Domain Inhibitors to Treat Anemia in Chronic Kidney Disease.

Contrib Nephrol 2019 16;198:112-123. Epub 2019 Apr 16.

Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan,

Background: Hypoxia-inducible factor (HIF) stabilizers, also known as inhibitors of HIF prolyl hydroxylase domain (PHD) inhibitors enzymes, are novel small-molecule agents to treat renal anemia. They increase endogenous erythropoietin (EPO) production by stabilizing HIF. This review focuses on the mechanisms by which PHD inhibitors ameliorate anemia in chronic kidney disease (CKD) and summarizes the current clinical experience with and prospects for these drugs. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/496531
Publisher Site
http://dx.doi.org/10.1159/000496531DOI Listing
April 2019
2 Reads

Anemia Management Considering the Pathophysiology of Elderly Chronic Kidney Disease Patients.

Contrib Nephrol 2019 16;198:135-143. Epub 2019 Apr 16.

Department of Internal Medicine, Division of Kidney and Dialysis, Hyogo College of Medicine, Nishinomiya, Japan.

The results of previous large clinical trials have revealed that low hemoglobin (Hb) levels are significantly associated with adverse events (cardiovascular disease, infection, hospitalization, and mortality) in patients with chronic kidney disease (CKD). However, in the general population, the mean Hb levels differ by sex and age. Furthermore, the comorbidities and activities of daily living of elderly patients are markedly different from those of nonelderly patients. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/496528
Publisher Site
http://dx.doi.org/10.1159/000496528DOI Listing
April 2019
3 Reads

Iron Metabolism in Chronic Kidney Disease Patients.

Contrib Nephrol 2019 16;198:103-111. Epub 2019 Apr 16.

Division of Nephrology, Department of Medicine, Showa University, School of Medicine, Tokyo, Japan.

Background: Anemia is a common comorbidity in patients with chronic kidney disease (CKD) and occurs due to diminished renal function. The main cause of such anemia is decreased erythropoietin (EPO) production and secretion from the kidney and a lower erythropoietic response to EPO. Treatment therefore involves erythropoiesis-stimulating agents (ESAs). Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/496369
Publisher Site
http://dx.doi.org/10.1159/000496369DOI Listing
April 2019
2 Reads

Rh phenotype caused by a novel RHAG mutation, c.945+1G>A, in the Japanese population.

Transfusion 2019 Apr 16. Epub 2019 Apr 16.

Department of Transfusion Medicine, Cell Therapy and Regenerative Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan.

Background: The Rh complex contributes to cell membrane structural integrity of erythrocytes. Rh syndrome is characterized by the absence of the Rh antigen on the erythrocyte membrane, resulting in chronic hemolytic anemia. We recently came across 3 Rh phenotype probands within two families with the same novel RHAG mutation in the Japanese population. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/trf.15312
Publisher Site
http://dx.doi.org/10.1111/trf.15312DOI Listing
April 2019
2 Reads

Ferric Citrate Attenuates Cardiac Hypertrophy and Fibrosis in a Rat Model of Chronic Kidney Disease.

Iran J Kidney Dis 2019 Mar;13(2):98-104

Division of Nephrology and Hypertension, Department of Medicine, University of California, Irvine, USA.

Introduction: Chronic kidney disease (CKD) promotes hypertrophy and fibrosis in heart, and increases the risk of cardiovascular mortality. Ferric citrate is a dietary phosphate binder used to control hyperphosphatemia in CKD patients. It has been shown to raise iron stores, improve anemia and secondary hyperparathyroidism, and decrease vascular calcification in CKD patients. Read More

View Article

Download full-text PDF

Source
March 2019
1 Read

Safety of Dynamic Intravenous Iron Administration Strategies in Hemodialysis Patients.

Clin J Am Soc Nephrol 2019 Apr 15. Epub 2019 Apr 15.

Department of Epidemiology.

Background And Objectives: Intravenous iron therapy for chronic anemia management is largely driven by dosing protocols that differ in intensity with respect to dosing approach (, dose, frequency, and duration). Little is known about the safety of these protocols.

Design, Setting, Participants, & Measurements: Using clinical data from a large United States dialysis provider linked to health care utilization data from Medicare, we constructed a cohort of patients with ESKD aged ≥65 years who initiated and continued center-based hemodialysis for ≥90 days between 2009 and 2012, and initiated at least one of the five common intravenous iron administration strategies; ranked by intensity (the amount of iron given at moderate-to-high iron indices), the order of strategies was 3 (least intensive), 2 (less intensive), 1 (reference), 4 (more intensive), and 5 (most intensive). Read More

View Article

Download full-text PDF

Source
http://cjasn.asnjournals.org/lookup/doi/10.2215/CJN.03970318
Publisher Site
http://dx.doi.org/10.2215/CJN.03970318DOI Listing
April 2019
2 Reads

Pagophagia in men with iron-deficiency anemia.

Blood Cells Mol Dis 2019 Apr 7;77:72-75. Epub 2019 Apr 7.

Southern Iron Disorders Center, Birmingham, AL, USA; Department of Medicine, Brookwood Medical Center, Birmingham, AL, USA.

Few case series of pagophagia and iron deficiency include men. We performed a retrospective study of non-Hispanic white men with iron-deficiency anemia whose anemia and pagophagia, thrombocytosis, and thrombocytopenia (if present) resolved after iron replacement. Iron-deficiency anemia was defined as transferrin saturation (TS) <15%, serum ferritin (SF) <30 μg/L, and hemoglobin (Hb) <13. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10799796193013
Publisher Site
http://dx.doi.org/10.1016/j.bcmd.2019.04.002DOI Listing
April 2019
2 Reads

Carotid Endarterectomy in a Patient With Type 2 Myocardial Infarction During Preparation for Surgery: A Case Report.

A A Pract 2019 Apr 11. Epub 2019 Apr 11.

Vascular Surgery, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

We present a patient who was admitted for carotid endarterectomy due to tight carotid stenosis and recent amaurosis fugax. His medical history included significant coronary artery disease with stable angina pectoris, hypertension with wide pulse pressure, chronic renal failure, and anemia. During preparation for surgery, the patient developed type 2 myocardial infarction with prolonged chest pain, ST depressions on electrocardiogram, and significant troponin elevations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1213/XAA.0000000000001021DOI Listing
April 2019
2 Reads

Associations of Common Variants in and Genes with Hepcidin-25 and Iron Status Parameters in Patients with End-Stage Renal Disease.

Dis Markers 2019 7;2019:4864370. Epub 2019 Mar 7.

Clinic of Nephrology, Clinical Center of Serbia, Belgrade 11000, Serbia.

Background: Influence of A736V and (C282Y and H63D) polymorphisms on serum hepcidin-25 levels and iron status parameters in end-stage renal disease (ESRD) patients stratified according to gender has not been previously investigated. In addition, we aimed to evaluate the diagnostic accuracy of the parameters to separate iron-deficiency anemia (IDA) from anemia of chronic disease.

Materials And Methods: Iron status parameters and genetic analysis were performed in 126 ESRD patients and in 31 IDA patients as the control group. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/4864370DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431474PMC
March 2019
1 Read

Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre-ibrutinib era: Incidence and risk factors.

Cancer Med 2019 Apr 14. Epub 2019 Apr 14.

William Jennings Bryan Dorn Veterans Affairs Medical Center, Columbia, South Carolina.

Chronic lymphocytic leukemia (CLL) patients are at increased risk for major hemorrhage (MH). We examined incidence of and risk factors for MH in CLL patients before introduction of newer CLL therapies such as ibrutinib, which includes bleeding risk. This study included 24 198 CLL patients treated in the VA system before FDA approval of ibrutinib as CLL therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2134DOI Listing
April 2019
2 Reads

[Endoscopy, angiography, surgery: diagnostic and therapeutic algorithms for diverticular bleeding].

Authors:
W Schwenk

Chirurg 2019 Apr 11. Epub 2019 Apr 11.

Klinik für Allgemein‑, Viszeral- und Gefäßchirurgie, Städtisches Klinikum Solingen gGmbH, Gotenstraße 1, 42653, Solingen, Deutschland.

Diverticular bleeding is a complication of diverticular disease but in contrast to diverticulitis, publications concerning diverticular bleeding are less common. Diverticular bleeding is the cause of approximately 20-50% of cases of lower gastrointestinal bleeding and in rare cases can be life-threatening. The main symptom of diverticular hemorrhage is painless hematochezia and the German guidelines recommend that further diagnostics of suspected diverticular bleeding should be performed in hospital. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00104-019-0950-0
Publisher Site
http://dx.doi.org/10.1007/s00104-019-0950-0DOI Listing
April 2019
5 Reads

Predicted coronary occlusion and Impella salvage during valve-in-valve transcatheter aortic valve replacement.

Cardiovasc Revasc Med 2019 Mar 29. Epub 2019 Mar 29.

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, United States of America.

We describe an interesting case of a 71 years old fragile female, with progressive shortness of breath on exertion and ankle swelling, cardiac failure NYHA class III. She also had chest irradiation due to Hodgkin's disease many years before, previous surgical aortic valve replacement using bioprosthetic stent-less Freestyle #25 mm valve (Medtronic, Inc) in 2000 for severe aortic stenosis, history of cardiac arrest in 2012 and angioplasty to ostial RCA, PCI to ostial RCA in 2014, CABG (RA graft to RCA) in 2014 (RCA intra-stent restenosis with refractory ischemia), anemia requiring regular transfusions, bronchiectasis and chronic kidney disease. Because of the great comorbidities, STS 4. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.03.019DOI Listing
March 2019
1 Read

[Association between anemia and chronic obstructive pulmonary disease exacerbations in Cartagena Colombia: a prospective cohort study].

Medwave 2019 Mar 26;19(2):e7602. Epub 2019 Mar 26.

Instituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.

Background: The presence of anemia in chronic obstructive pulmonary disease is not an infrequent event. Exacerbations of this disease have been associated with an increase in mortality in these patients. It is not clear if the presence of anemia is associated with the risk of exacerbations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5867/medwave.2019.02.7602DOI Listing
March 2019
3 Reads

Human parvovirus B19 in solid organ transplantation: Guidelines from the American society of transplantation infectious diseases community of practice.

Clin Transplant 2019 Apr 11:e13535. Epub 2019 Apr 11.

Department of Pediatrics, Infectious Diseases and Host Defense, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio.

Clinical manifestations of human parvovirus B19 infection can vary widely and may be atypical in solid organ transplant (SOT) recipients. However, disease is apparent when there is destruction of erythrocyte progenitor cells leading to severe acute or chronic anemia with lack of an appropriate reticulocyte response in the setting of active parvovirus B19 infection. Serology may not reliably establish the diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ctr.13535DOI Listing
April 2019
1 Read

Red blood cell utilization and transfusion triggers in patients diagnosed with chronic lymphocytic leukaemia in Iceland 2003-2016.

Vox Sang 2019 Apr 10. Epub 2019 Apr 10.

Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Background And Objectives: Revised Icelandic guidelines proposed a restrictive haemoglobin (Hb) threshold of 70 g/l for red blood cell (RBC) transfusions in general, but 100 g/l for malignancies/bone marrow suppression. Chronic lymphocytic leukaemia (CLL) is frequently complicated by anaemia. The objective was to investigate RBC transfusion practices in CLL. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/vox.12775
Publisher Site
http://dx.doi.org/10.1111/vox.12775DOI Listing
April 2019
4 Reads

The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research.

Front Physiol 2019 26;10:304. Epub 2019 Mar 26.

Van Creveldkliniek, Department of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

We provide an overview of the evidence for an erythropoietin-fibroblast growth factor 23 (FGF23) signaling pathway directly influencing erythroid cells in the bone marrow. We outline its importance for red blood cell production, which might add, among others, to the understanding of bone marrow responses to endogenous erythropoietin in rare hereditary anemias. FGF23 is a hormone that is mainly known as the core regulator of phosphate and vitamin D metabolism and it has been recognized as an important regulator of bone mineralization. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphys.2019.00304DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443968PMC
March 2019
2 Reads

Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update.

Blood Adv 2019 Apr;3(8):1197-1210

Western University, London, ON, Canada.

Purpose: To update the American Society of Clinical Oncology (ASCO)/American Society of Hematology (ASH) recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer.

Methods: PubMed and the Cochrane Library were searched for randomized controlled trials (RCTs) and meta-analyses of RCTs in patients with cancer published from January 31, 2010, through May 14, 2018. For biosimilar ESAs, the literature search was expanded to include meta-analyses and RCTs in patients with cancer or chronic kidney disease and cohort studies in patients with cancer due to limited RCT evidence in the cancer setting. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018030387DOI Listing
April 2019
2 Reads

Etanercept improved anemia and decreased hepcidin gene expression in a rat model of rheumatoid arthritis.

Biomed Pharmacother 2019 Apr 1;112:108740. Epub 2019 Mar 1.

Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Egypt.

Aim: Anemia of chronic disease is considered the most common extra-articular manifestation of rheumatoid arthritis (RA). The present study aimed to investigate the effect of etanercept (anti-tumor necrosis factor) on anemia and hepcidin gene expression in a rat model of RA.

Method: Rheumatoid arthritis was induced in rats by Freund Complete Adjuvant (FCA; 1 mg/0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopha.2019.108740DOI Listing
April 2019
1 Read

Comparison of the Clinical Characteristics and Outcomes between Leprosy-Affected Persons in Sorokdo and the General Population Affected by Chronic Hepatitis C in Korea.

Gut Liver 2019 Feb 27. Epub 2019 Feb 27.

Department of Gastroenterology, Chonnam National University Hospital, Gwangju, South Korea.

Background/aims: : Patients with Hansen’s disease are the most vulnerable to hepatitis C; however, no data on the treatment efficacy of direct-acting antiviral agents (DAAs) are available in this group. Therefore, we elucidated the prevalence and clinical outcomes of hepatitis C in persons affected by leprosy in Sorokdo, Jeollanam-do, Korea.

Methods: : We retrospectively included 50 leprosy patients with positive hepatitis C virus (HCV) RNA test results (group A) hospitalized at the Sorokdo National Hospital from May 2016 to March 2018 and 73 patients with chronic hepatitis C who were treated with DAAs at the Chonnam National University Hospital (group B) from May 2016 to December 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5009/gnl18432DOI Listing
February 2019
1 Read

Posttransplantation Anemia in Kidney Transplant Recipients.

Acta Haematol 2019 Apr 10;142(1):37-43. Epub 2019 Apr 10.

Nephrology and Transplantation Immunology Laboratory, Rabin Medical Center, Petah Tikva, Israel.

Posttransplantation anemia (PTA) is common among kidney transplant patients. Early PTA is usually defined as anemia which develops up to 6 months after transplantation, and late PTA is defined as anemia which develops after 6 months. There are multiple causes, with iron deficiency being the major contributor. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000496140DOI Listing
April 2019
1 Read

Iron Deficiency Anemia in Chronic Kidney Disease.

Acta Haematol 2019 Apr 10;142(1):44-50. Epub 2019 Apr 10.

Nephrology and Hypertension Unit, Rabin Medical Center, Petah Tikva, Israel.

Iron deficiency anemia is a common complication of chronic kidney disease (CKD). CKD patients suffer from both absolute and functional iron deficiency. Absolute iron deficiency is defined by severely reduced or absent iron stores, while functional iron deficiency is defined by adequate iron stores but insufficient iron availability for incorporation into erythroid precursors. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000496492DOI Listing
April 2019
1 Read

Management of Iron Deficiency Anaemia in Inflammatory Bowel Disease.

Acta Haematol 2019 Apr 10;142(1):30-36. Epub 2019 Apr 10.

Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria,

Inflammatory bowel disease (IBD) is a group of chronic relapsing inflammatory disorders affecting the large and small intestine, with a rising worldwide incidence and prevalence. Anaemia is the most common extraintestinal manifestation of IBD, correlating with disease activity, and tending to relapse even after successful therapy. Iron deficiency is the most common cause; however, it often manifests in combination with anaemia of inflammation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000496728DOI Listing
April 2019
1 Read

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update.

J Clin Oncol 2019 Apr 10:JCO1802142. Epub 2019 Apr 10.

13 Western University, London, Ontario, Canada.

Purpose: To update the American Society of Clinical Oncology (ASCO)/American Society of Hematology (ASH) recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer.

Methods: PubMed and the Cochrane Library were searched for randomized controlled trials (RCTs) and meta-analyses of RCTs in patients with cancer published from January 31, 2010, through May 14, 2018. For biosimilar ESAs, the literature search was expanded to include meta-analyses and RCTs in patients with cancer or chronic kidney disease and cohort studies in patients with cancer due to limited RCT evidence in the cancer setting. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.02142DOI Listing
April 2019
1 Read

Evaluation of reticulocyte hemoglobin for assessment of anemia in rheumatological disorders.

Int J Rheum Dis 2019 Apr 9. Epub 2019 Apr 9.

Department of Haematology and Clinical Pathology, Sir Ganga Ram Hospital, New Delhi, India.

Objective: The aim of this study was to evaluate the role of reticulocyte hemoglobin (Ret He) estimation in subtyping of anemia and to find the correlation of Ret He with the severity of anemia.

Methods: Ninety-four patients with rheumatic diseases with anemia were enrolled. Blood samples were taken to determine various parameters. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/1756-185X.13
Publisher Site
http://dx.doi.org/10.1111/1756-185X.13567DOI Listing
April 2019
4 Reads
1.771 Impact Factor

Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review.

Pharmacoecon Open 2019 Apr 9. Epub 2019 Apr 9.

Otsuka Pharmaceutical Development and Commercialization, Rockville, MD, USA.

Background: The cost and health-related quality of life (HRQoL) burden associated with treatments for anaemia of chronic kidney disease (CKD) is not well characterized among non-dialysis-dependent (NDD) patients.

Objective: Our objective was to review the literature on costs and HRQoL associated with current treatments for anaemia of CKD among NDD patients.

Methods: The Cochrane Library, MEDLINE, Embase, NHS EED, and NHS HTA databases were searched for original studies published in English between 1 January 2000 and 17 March 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s41669-019-0132-5DOI Listing
April 2019
3 Reads

Mesh plug migration into the small intestine: An unusual cause of chronic anemia.

Dig Liver Dis 2019 Apr 6. Epub 2019 Apr 6.

Department of Gastroenterology and Hepatology, Mie University Hospital, Tsu, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2019.03.009DOI Listing

Mild Hereditary Spherocytosis without Accompanying Hereditary Haemochromatosis: An Unrecognised Cause of Iron Overload.

Acta Haematol 2019 Apr 9;141(4):256-260. Epub 2019 Apr 9.

Department of Paediatrics, Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada,

Hereditary spherocytosis (HS) is a common inherited haemolytic anaemia and has great variability in its presentation. Non-transfusion iron overload in HS has only been reported with co-inheritance of hereditary haemochromatosis (HHC). We present 4 unrelated patients of East Asian ethnicity with mild HS and significant non-transfusion iron overload in the absence of known disease-causing mutations in HHC genes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000497175DOI Listing
April 2019
1 Read
0.994 Impact Factor

A nationwide comparative analysis of medical complications in fibromyalgia patients following total knee arthroplasty.

Ann Transl Med 2019 Feb;7(4):64

Department of Orthopaedic Surgery, Lenox Hill Hospital, Northwell Health, New York, NY, USA.

Background: Fibromyalgia is a disease primarily characterized by chronic widespread pain and associated symptoms of fatigue, mild cognitive impairment, and sleep disturbance. The condition affects 1% to 6% of the general population in the United States and is more commonly diagnosed in women (2:1 ratio). There is evidence to suggest that fibromyalgia patients may be more at risk of postoperative complications. Read More

View Article

Download full-text PDF

Source
http://atm.amegroups.com/article/view/23335/22774
Publisher Site
http://dx.doi.org/10.21037/atm.2018.12.60DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409227PMC
February 2019
7 Reads

Osteomyelitis Caused by Carbapenemase-Producing Klebsiella Pneumoniae: A Diagnosis to Consider in Patients with Hematologic Malignancies and Stem Cell Transplant Recipients.

Am J Case Rep 2019 Apr 9;20:482-488. Epub 2019 Apr 9.

Department of Hematology and Bone Marrow Transplantation, Hospital de Santa Maria, CHLN - EPE, Lisboa, Portugal.

BACKGROUND Osteomyelitis (OM) due to carbapenemase-producing Klebsiella pneumoniae (CPKp) is a very rare but severe condition, particularly among patients with hematologic malignancies and stem cell transplant recipients, who are especially at risk of developing nosocomial infections caused by this bacterium. CASE REPORT We describe 2 cases of acute and chronic OM by CPKp in adults with hematologic disorders. Patient 1, with acute lymphoblastic leukemia, developed bacteremia due to multidrug CPKp after induction chemotherapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12659/AJCR.909965DOI Listing
April 2019
1 Read

Jaundice and anaemia as presenting features of an incomplete autoimmune polyglandular syndrome type II.

BMJ Case Rep 2019 Apr 8;12(4). Epub 2019 Apr 8.

Department of General Medicine, R.G. Kar Medical College and Hospital, Kolkata, India.

The coexistence of adrenal failure with either autoimmune thyroid disease and/or type 1 diabetes is defined as autoimmune polyglandular syndrome (APS) type 2 or Schmidt's syndrome. Vitiligo, hypergonadotropic hypogonadism, chronic autoimmune hepatitis, alopecia, pernicious anaemia and seronegative arthritis may also be present. We present a case of 45-year-old Indian man with progressive jaundice and asthenia for 3 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2018-228490DOI Listing
April 2019
1 Read

"Doctor, can I have less frequent injection with highly efficient treatment?" A patient centered study using an electronic choice-based conjoint analysis (ePRO) to assess real world preferences regarding erythropoiesis stimulating agent to treat anaemia in chronic kidney disease (PERCEPOLIS study).

Nephrol Ther 2019 Apr 5. Epub 2019 Apr 5.

Nephrology unit, Nîmes University Hospital, 30029 Nîmes, France.

Objectives: Patient's perception analysis appears recently in numerous studies. Conjoint analysis has been used extensively by market researchers for studying how people value the characteristics of products and services. This technique was used in a clinical study to describe perceptions and preferences of anaemic patients suffering from chronic kidney disease not on dialysis (CKDnd), regarding erythropoietin stimulating agents (ESA). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nephro.2018.11.009DOI Listing
April 2019
1 Read

Update on Feline Hemoplasmosis.

Authors:
Emi N Barker

Vet Clin North Am Small Anim Pract 2019 Apr 5. Epub 2019 Apr 5.

Langford Vets, University of Bristol, Bristol BS40 5DU, UK. Electronic address:

"The wall-less, hemotropic, mycoplasma species Mycoplasma haemofelis, "Candidatus Mycoplasma turicensis" and, to a lesser extent, "Candidatus Mycoplasma haemominutum" have the potential to induce clinical hemolytic anemia in infected cats. Prevalence varies markedly between infecting species, complicated by a chronic carrier state. Accurate and prompt confirmation of infection and identification of the infecting hemoplasma species enables appropriate antibiotics (eg, tetracycline; fluoroquinolone) to be prescribed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cvsm.2019.02.009DOI Listing

Quality of life among patients with moderate to advanced chronic kidney disease in Ghana - a single centre study.

BMC Nephrol 2019 Apr 8;20(1):122. Epub 2019 Apr 8.

Department of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, School of Medical Sciences, Kumasi, Ghana.

Background: The prevalence of chronic kidney disease (CKD) is increasing worldwide and in Africa. Health related quality of life (QOL) has become an essential outcome measure for patients with CKD and end stage renal disease (ESRD). There is growing interest worldwide in QOL of CKD patients but paucity of data in Ghana. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12882-019-1316-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454740PMC
April 2019
1 Read

Thyroidectomy Complications in Patients with Diabetes Mellitus.

Otolaryngol Head Neck Surg 2019 Apr 9:194599819835793. Epub 2019 Apr 9.

1 Department of Otolaryngology-Head and Neck Surgery, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York, USA.

Objective: To (1) analyze postoperative thyroidectomy outcomes in patients with diabetes mellitus (DM), who are prone to deleterious effects of glucose dysmetabolism, and (2) apply findings to optimize perioperative management of diabetics requiring thyroid surgery.

Study Design: Retrospective database analysis.

Setting: University hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0194599819835793DOI Listing
April 2019
1 Read

Biochemical effects and safety of Gum arabic () supplementation in patients with sickle cell anemia.

Blood Res 2019 Mar 21;54(1):31-37. Epub 2019 Mar 21.

Department of Physiology, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.

Background: Sickle cell anemia (SCA) is a hereditary chronic hemolytic anemia with several clinical consequences. Intravascular sickling of red blood cells leads to multi-organ dysfunction. Moreover, several biochemical abnormalities have been associated with SCA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2019.54.1.31DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439290PMC
March 2019
2 Reads

Molecular perspective of iron uptake, related diseases, and treatments.

Blood Res 2019 Mar 21;54(1):10-16. Epub 2019 Mar 21.

Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

Iron deficiency anemia and anemia of chronic disorders are the most common types of anemia. Disorders of iron metabolism lead to different clinical scenarios such as iron deficiency anemia, iron overload, iron overload with cataract and neurocognitive disorders. Regulation of iron in the body is a complex process and different regulatory proteins are involved in iron absorption and release from macrophages into hematopoietic tissues. Read More

View Article

Download full-text PDF

Source
https://synapse.koreamed.org/DOIx.php?id=10.5045/br.2019.54.
Publisher Site
http://dx.doi.org/10.5045/br.2019.54.1.10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439303PMC
March 2019
3 Reads